Trials / Conditions / T-cell Acute Lymphoblastic Lymphoma

T-cell Acute Lymphoblastic Lymphoma

8 registered clinical trials studyying T-cell Acute Lymphoblastic Lymphoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells NCT07220993	Baylor College of Medicine	Phase 1
Recruiting	Universal 4SCAR7U Targeting CD7-positive Malignancies NCT05995028	Shenzhen Geno-Immune Medical Institute	Phase 1
Recruiting	Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL NCT04972942	New York Medical College	Phase 1
Recruiting	Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells NCT03690011	Baylor College of Medicine	Phase 1
Unknown	Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances NCT04934774	iCell Gene Therapeutics	Phase 1
Unknown	Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies NCT05127135	Fundamenta Therapeutics, Ltd.	Phase 1
Unknown	Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies NCT04033302	Shenzhen Geno-Immune Medical Institute	Phase 1 / Phase 2
Recruiting	Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Anti NCT03081910	Baylor College of Medicine	Phase 1